Similar articles

• [Erythrocyte kinetics in myelodysplastic syndromes].

  Mistrík M. Mistrík M. Vnitr Lek. 1991 Feb;37(2):166-71. Vnitr Lek. 1991. PMID: 2021077 Slovak.
• [Myelodysplastic syndromes and refractory anemias with reference to the erythropoietic abnormalities].

  Yoshida Y. Yoshida Y. Nihon Rinsho. 1991 Mar;49(3):587-92. Nihon Rinsho. 1991. PMID: 2041184 Japanese. No abstract available.
• Ferrokinetics: methods and interpretation.

  Ricketts C, Cavill I. Ricketts C, et al. Clin Nucl Med. 1978 Apr;3(4):159-64. doi: 10.1097/00003072-197804000-00014. Clin Nucl Med. 1978. PMID: 657685
• [Ferrokinetics].

  Takahashi Y, Umadome H, Ohno Y. Takahashi Y, et al. Nihon Rinsho. 1997 Mar;55 Suppl 1:75-83. Nihon Rinsho. 1997. PMID: 9097562 Review. Japanese. No abstract available.
• Sideroblasts in myelodysplasia: their nature and clinical significance.

  Hast R. Hast R. Scand J Haematol Suppl. 1986;45:53-5. doi: 10.1111/j.1600-0609.1986.tb00843.x. Scand J Haematol Suppl. 1986. PMID: 3515519 Review. No abstract available.